Stimulation of cell growth and resistance to apoptosis in vascular smooth muscle cells on a chondroitin sulfate/epidermal growth factor coating

Biomaterials

Volumn 32, Issue 6, 2011, Pages 1591-1600

  Charbonneau, Cindy ^a,d   Liberelle, Benoît ^c   Hébert, Marie Josée ^a   De Crescenzo, Gregory ^c   Lerouge, Sophie ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ÉCOLE DE TECHNOLOGIE SUPÉRIEURE   (Canada)

^c ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Bioactive coating; Chondroitin sulfate; Endovascular aneurysm repair; Epidermal growth factor; Vascular smooth muscle cells

Indexed keywords

APOPTOSIS; BIOACTIVE COATINGS; CHONDROITIN SULFATES; ENDOVASCULAR; EPIDERMAL GROWTH FACTORS; VASCULAR SMOOTH MUSCLE CELLS;

ADHESION; BIOLOGICAL MATERIALS; BLOOD VESSEL PROSTHESES; BLOOD VESSELS; CELL ADHESION; CELL DEATH; CELL GROWTH; COATINGS; CONTACT ANGLE; GRAFTING (CHEMICAL); GROWTH KINETICS; MUSCLE; PEPTIDES; REPAIR; SECONDARY ION MASS SPECTROMETRY;

CELL IMMOBILIZATION;

BIOMATERIAL; CHONDROITIN SULFATE; CYANAMIDE; EPIDERMAL GROWTH FACTOR;

ABDOMINAL AORTA ANEURYSM; ANEURYSM SURGERY; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL GROWTH; CELL STIMULATION; CONTACT ANGLE; CONTROLLED STUDY; COVALENT BOND; CULTURE MEDIUM; ELLIPSOMETRY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SURFACE PROPERTY; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHONDROITIN SULFATES; EPIDERMAL GROWTH FACTOR; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS;

RATTUS;

EID: 78650291467     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.10.055     Document Type: Article

References (36)

1. Malina M., Brunkwall J., Ivancev K., Jonsson J., Malina J., Lindblad B. Endovascular healing is inadequate for fixation of Dacron stent-grafts in human aortoiliac vessels. Eur J Vasc Endovasc Surg 2000, 19(1):5-11.
2. Jacob T., Ascher E., Hingorani A., Gunduz Y., Kallakuri S. Initial steps in the unifying theory of the pathogenesis of artery aneurysms. J Surg Res 2001, 101(1):37-43.
3. Rowe V.L., Stevens S.L., Reddick T.T., Freeman M.B., Donnell R., Carroll R.C., et al. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas. J Vasc Surg 2000, 31(3):567-576.
4. Thompson R.W., Liao S., Curci J.A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis 1997, 8(10):623-631.
5. Henderson E.L., Geng Y.J., Sukhova G.K., Whittemore A.D., Knox J., Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999, 99(1):96-104.
6. Bacakova L., Filova E., Rypacek F., Svorcik V., Stary V. Cell adhesion on artificial materials for tissue engineering. Physiol Res 2004, 53(Suppl. 1):S35-S45.
7. Michel J.B. Anoikis in the cardiovascular system: known and unknown extracellular mediators. Arterioscler Thromb Vasc Biol 2003, 23(12):2146-2154.
8. Lerouge S., Major A., Girault-Lauriault P.L., Raymond M.A., Laplante P., Soulez G., et al. Nitrogen-rich coatings for promoting healing around stent-grafts after endovascular aneurysm repair. Biomaterials 2007, 28(6):1209-1217.
9. Pollman M.J., Hall J.L., Mann M.J., Zhang L., Gibbons G.H. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med 1998, 4(2):222-227.
10. Laplante P., Raymond M.A., Gagnon G., Vigneault N., Sasseville A.M., Langelier Y., et al. Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis. J Immunol 2005, 174(9):5740-5749.
11. Raymond M.A., Desormeaux A., Laplante P., Vigneault N., Filep J.G., Landry K., et al. Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. FASEB J 2004, 18(6):705-707.
12. Rammelt S., Illert T., Bierbaum S., Scharnweber D., Zwipp H., Schneiders W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006, 27(32):5561-5571.
13. Reyes J.M., Herretes S., Pirouzmanesh A., Wang D.A., Elisseeff J.H., Jun A., et al. A modified chondroitin sulfate aldehyde adhesive for sealing corneal incisions. Invest Ophthalmol Vis Sci 2005, 46(4):1247-1250.
14. Gilbert M.E., Kirker K.R., Gray S.D., Ward P.D., Szakacs J.G., Prestwich G.D., et al. Chondroitin sulfate hydrogel and wound healing in rabbit maxillary sinus mucosa. Laryngoscope 2004, 114(8):1406-1409.
15. Major T.C., Keiser J.A. Inhibition of cell growth: effects of the Tyrosine Kinase Inhibitor CGP 53716. J Pharmacol Exp Ther 1997, 283(1):402-410.
16. Henson E.S., Gibson S.B. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. Cell Signal 2006, 18(12):2089-2097.
17. Seurynck-Servoss S.L., White A.M., Baird C.L., Rodland K.D., Zangar R.C. Evaluation of surface chemistries for antibody microarrays. Anal Biochem 2007, 371(1):105-115.
18. Boucher C., Liberelle B, Jolicoeur M., Durocher Y., De Crescenzo G. Epidermal growth factor tethered through coiled-coil interactions induces cell surface receptor phosphorylation. Bioconjug Chem 2009, 20(8):1569-1577.
19. Liberelle B., Banquy X., Giasson S. Stability of silanols and grafted alkylsilane monolayers on plasma-activated mica surfaces. Langmuir 2008, 24(7):3280-3288.
20. Grabarek Z., Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185(1):131-135.
21. Wetterö J., Askendal A., Bengtsson T., Tengvall P. On the binding of complement to solid artificial surfaces in vitro. Biomaterials 2002, 23(4):981-991.
22. van der Bas J.M., Quax P.H., van den Berg A.C., van Hinsbergh V.W., van Bockel J.H. Ingrowth of aorta vascular cells into basic fibroblast growth factor-impregnated vascular prosthesis material: a porcine and human in vitro study on blood vessel prosthesis healing. J Vasc Surg 2002, 36(6):1237-1247.
23. van der Bas J.M., Quax P.H., van den Berg A.C., Visser M.J., van der Linden E., van Bockel J.H. Ingrowth of aorta wall into stent grafts impregnated with basic fibroblast growth factor: a porcine in vivo study of blood vessel prosthesis healing. J Vasc Surg 2004, 39(4):850-858.
24. Kusanagi M., Matsui O., Sanada J., Ogi T., Takamatsu S., Zhong H., et al. Hydrogel-mediated release of basic fibroblast growth factor from a stent-graft accelerates biological fixation with the aortic wall in a porcine model. J Endovasc Ther 2007, 14(6):785-793.
25. Masaki K., Takatsugu S., Koji H., Yoichiro M., Noriyuki K., Kyoko I.-Y., et al. Basic fibroblast growth factor slow release stent graft for endovascular aortic aneurysm repair: a canine model experiment. J Vasc Surg 2008, 48(5):1306-1314.
26. Pieper J.S., Oosterhof A., Dijkstra P.J., Veerkamp J.H., van Kuppevelt T.H. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate. Biomaterials 1999, 20(9):847-858.
27. Popplewell J.F., Swann M.J., Ahmed Y., Turnbull J.E., Fernig D.G. Fabrication of carbohydrate surfaces by using nonderivatised oligosaccharides, and their application to measuring the assembly of sugar-protein complexes. Chembiochem 2009, 10(7):1218-1226.
28. Raymond M.A., Vigneault N., Luyckx V., Hebert M.J. Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells. Biochem Biophys Res Commun 2002, 291(2):261-269.
29. Chupa J.M., Foster A.M., Sumner S.R., Madihally S.V., Matthew H.W. Vascular cell responses to polysaccharide materials: in vitro and in vivo evaluations. Biomaterials 2000, 21(22):2315-2322.
30. Kaiura T.L., Itoh H., Kubaska S.M., McCaffrey T.A., Liu B., Kent K.C. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg 2000, 31(3):577-584.
31. Ying W.Z., Zhang H.G., Sanders P.W. EGF receptor activity modulates apoptosis induced by inhibition of the proteasome of vascular smooth muscle cells. J Am Soc Nephrol 2007, 18(1):131-142.
32. Ichinose J., Morimatsu M., Yanagida T., Sako Y. Covalent immobilization of epidermal growth factor molecules for single-molecule imaging analysis of intracellular signaling. Biomaterials 2006, 27(18):3343-3350.
33. Stefonek T.J., Masters K.S. Immobilized gradients of epidermal growth factor promote accelerated and directed keratinocyte migration. Wound Repair Regen 2007, 15(6):847-855.
34. Nakaji-Hirabayashi T., Kato K., Arima Y., Iwata H. Oriented immobilization of epidermal growth factor onto culture substrates for the selective expansion of neural stem cells. Biomaterials 2007, 28(24):3517-3529.
35. Boucher C., Ruiz J.-C., Thibault M., Buschmann M.D., Wertheimer M.R., Jolicoeur M., et al. Human corneal epithelial cell response to epidermal growth factor tethered via coiled-coil interactions. Biomaterials 2010, 31(27):7021-7031.
36. Klenkler B.J., Griffith M., Becerril C., West-Mays J.A., Sheardown H. EGF-grafted PDMS surfaces in artificial cornea applications. Biomaterials 2005, 26(35):7286-7296.